Key figures

Key figures

 
  2022 2021 2020 2019 2018
in CHF millions          
Net sales 725 497 445 525 534
Gross profit 294 161 190 227 222
Gross profit margin 40.6% 32.3% 42.8% 43.2% 41.7%
EBITDA Chemistry 19 20 9 9 11
EBITDA Paper 81 -8 17 55 51
EBITDA Packaging 31 12 28 24 22
EBITDA Other/Consolidation - 2 1 - -1
EBITDA 131 26 55 88 83
EBITDA-Marge 18.1% 5.2% 12.4% 16.8% 15.6%
EBIT 112 -31 25 57 52
EBIT margin 15.5% -0.5% 5.5% 10.8% 9.7%
Net result 101 -151 47 48 42
Return on equity ROE 28.5% -38.7% 10.3% 11.4% 10.5%
Cash flow2 129 17 46 80 69
Cash flow from operating activities 98 16 55 61 64
Capital expenditures for fixed assets 34 25 19 23 24
Free cash flow 68 -3 40 40 20
Total assets 666 560 704 703 800
Shareholders´ equity 400 310 472 441 407
Equity ratio 60.0% 55.4% 67.0% 62.8% 50.9%
Net cash 45 -15 -2 -30 -57
Net debt to EBITDA ratio n.a. 0.6 0.0 0.3 0.7
Capital employed 344 319 468 477 470
Net operating profit after tax (NOPAT) 97 -2 20 49 44
Return on capital employed (ROCE) 29.2% -0.6% 4.3% 10.3% 9.3%
Headcount (FTE) 1181 1104 1098 1086 1081

1 before impairment
2 before change in non-financial net working capital

 

Share information

  2022 2021 2020 2019 2018
in CHF          
Share price as at 31. December 78.00 61.00 72.60 79.20 82.50
Price-earnings ratio as at 31. December 4.6 -2.4 9.3 9.8 11.7
Earnings per share 16.83 -25.26 7.82 8.06 7.05
Dividend per share 4.50 1) 1.30 1.80 1.80 1.80
Dividend yield 5.8% 2.1% 2.5% 2.3% 2.2%
Market capitalization (in CHF millions) 468 366 436 475 495

1) Board of Directors´ proposal to Annual General Meeting of 14 March 2023